Search results (224)
« Back to NewsNew research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
Study identifies key immune structures in the gut that may drive coeliac disease
6 May 2025
Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.
RDM researchers edit new edition of seminal haematology textbook
1 May 2025
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
Wellcome Career Development Award For Agne Antanaviciute
2 April 2025
Dr Agne Antanaviciute has won a Wellcome Career Development Award for her research investigating early-life immunity.
Technician Champion appointed in RDM
2 April 2025
Facility Manager Michalina Mazurczyk, based in the MRC Weatherall Institute of Molecular Medicine, has been appointed as Technician Champion for the second year.
New study reveals details of key immune mechanism
25 March 2025
An international collaboration, initiated by the Jackson Group at the MRC WIMM, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
Ancient genomic linkage regulates red blood cell development
24 March 2025
A collaboration between the Drakesmith and Higgs Groups at the MRC WIMM has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Wellcome Career Development Award For Sumana Sharma
14 March 2025
Dr Sumana Sharma has won a Wellcome Career Development Award for her research investigating receptors in T cells.
Adam Wilkinson wins 2025 ISEH Janet Rowley Award
13 March 2025
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
International Women's Day 2025
7 March 2025
For International Women's Day on 8th March 2025, women from the MRC WIMM reflect on why this day is so important, the barriers and biases women can face in their careers, and which women have inspired them.
Rare Disease Day 2025
27 February 2025
For Rare Disease Day on the 28th February, we spoke to three of our researchers about their work, discussing both the challenges and importance of researching and treating rare diseases.
Therapy Acceleration Lab granted UKAS accreditation
27 February 2025
The Therapy Acceleration Lab (TAL) at the MRC WIMM was recently accredited by the United Kingdom Accreditation Service (UKAS) to the ISO 17025:2017 Standard as a testing laboratory, No. 28562.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
21 February 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
MRC WIMM researchers win 2024 RDM Graduate Prize
28 January 2025
Congratulations to Charlotte Brierley and Patrick Pflughaupt, who were both awarded the 2024 RDM Graduate Prize after completing their PhDs at the MRC WIMM.
Funding awarded for new theatre-based community engagement project
23 January 2025
Alison Kay and Anne Goriely, together with Minna Jeffery (St. Anne’s College) and Lisa Hinton (Nuffield Dept. of Primary Care Health Sciences), have won an award from the University of Oxford’s PCER Fund for a project called “Making it personal”, which will use theatre to explore public perception of a new form of genetic testing.